Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)

  • STATUS
    Recruiting
  • participants needed
    600
  • sponsor
    H. Lundbeck A/S
Updated on 18 June 2021
Investigator
Email contact via H. Lundbeck A/S
Primary Contact
US1310 (2.0 mi away) Contact
+182 other location
major depressive disorder
fluoxetine
vortioxetine

Summary

Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric patients (age 7 to 11 years)

Details
Condition Major depression, major depressive disorders
Treatment Placebo, Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day
Clinical Study IdentifierNCT02709655
SponsorH. Lundbeck A/S
Last Modified on18 June 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note